105 related articles for article (PubMed ID: 24774829)
1. Words of wisdom. Re: Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial.
van der Poel H
Eur Urol; 2014 Jun; 65(6):1221-2. PubMed ID: 24774829
[No Abstract] [Full Text] [Related]
2. Transurethral surgery and twice-daily radiation plus paclitaxel-cisplatin or fluorouracil-cisplatin with selective bladder preservation and adjuvant chemotherapy for patients with muscle invasive bladder cancer (RTOG 0233): a randomised multicentre phase 2 trial.
Mitin T; Hunt D; Shipley WU; Kaufman DS; Uzzo R; Wu CL; Buyyounouski MK; Sandler H; Zietman AL
Lancet Oncol; 2013 Aug; 14(9):863-72. PubMed ID: 23823157
[TBL] [Abstract][Full Text] [Related]
3. A phase I/II trial of transurethral surgery combined with concurrent cisplatin, 5-fluorouracil and twice daily radiation followed by selective bladder preservation in operable patients with muscle invading bladder cancer.
Zietman AL; Shipley WU; Kaufman DS; Zehr EM; Heney NM; Althausen AF; McGovern FJ
J Urol; 1998 Nov; 160(5):1673-7. PubMed ID: 9783929
[TBL] [Abstract][Full Text] [Related]
4. The long road to bladder sparing in muscle invasive cancer.
Martinez-Fernandez A
Lancet Oncol; 2013 Aug; 14(9):795-6. PubMed ID: 23823160
[No Abstract] [Full Text] [Related]
5. Phase I-II RTOG study (99-06) of patients with muscle-invasive bladder cancer undergoing transurethral surgery, paclitaxel, cisplatin, and twice-daily radiotherapy followed by selective bladder preservation or radical cystectomy and adjuvant chemotherapy.
Kaufman DS; Winter KA; Shipley WU; Heney NM; Wallace HJ; Toonkel LM; Zietman AL; Tanguay S; Sandler HM
Urology; 2009 Apr; 73(4):833-7. PubMed ID: 19100600
[TBL] [Abstract][Full Text] [Related]
6. Clinical outcome in patients with locally advanced bladder carcinoma treated with conservative multimodality therapy.
George L; Bladou F; Bardou VJ; Gravis G; Tallet A; Alzieu C; Serment G; Salem N
Urology; 2004 Sep; 64(3):488-93. PubMed ID: 15351577
[TBL] [Abstract][Full Text] [Related]
7. A case of T2 muscle-invasive bladder cancer treated with neoadjuvant chemotherapy.
Gilbert SM; Lee CT
Nat Clin Pract Urol; 2006 Dec; 3(12):675-9. PubMed ID: 17149384
[TBL] [Abstract][Full Text] [Related]
8. Neoadjuvant combined modality program with selective organ preservation for invasive bladder cancer: results of Radiation Therapy Oncology Group phase II trial 8802.
Tester W; Caplan R; Heaney J; Venner P; Whittington R; Byhardt R; True L; Shipley W
J Clin Oncol; 1996 Jan; 14(1):119-26. PubMed ID: 8558186
[TBL] [Abstract][Full Text] [Related]
9. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Maarouf AM; Khalil S; Salem EA; ElAdl M; Nawar N; Zaiton F
BJU Int; 2011 May; 107(10):1605-10. PubMed ID: 20825396
[TBL] [Abstract][Full Text] [Related]
10. Bladder preservation multimodality therapy as an alternative to radical cystectomy for treatment of muscle invasive bladder cancer.
Choudhury A; Cowan R
BJU Int; 2011 Nov; 108(9):E313. PubMed ID: 22023065
[No Abstract] [Full Text] [Related]
11. Selective organ preservation in muscle-invasive bladder cancer: review of the literature.
Khosravi-Shahi P; Cabezón-Gutiérrez L
Surg Oncol; 2012 Mar; 21(1):e17-22. PubMed ID: 22088598
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant therapy for locally invasive bladder cancer: results of randomized trials in 40 patients.
Ozono S; Kawata Y; Fukui Y; Fujimoto K; Iwai A; Matsuki H; Samma S; Hirao Y; Okajima E
Urol Int; 1991; 47 Suppl 1():116-9. PubMed ID: 1949366
[TBL] [Abstract][Full Text] [Related]
13. An update of selective bladder preservation by combined modality therapy for invasive bladder cancer.
Shipley WU; Kaufman DS; Heney NM; Althausen AF; Zietman AL
Eur Urol; 1998; 33 Suppl 4():32-4. PubMed ID: 9615208
[No Abstract] [Full Text] [Related]
14. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer.
Freiha F; Reese J; Torti FM
J Urol; 1996 Feb; 155(2):495-9; discussion 499-500. PubMed ID: 8558644
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of systemic chemotherapy and intra-arterial chemotherapy with/without radiotherapy for bladder preservation or as neo-adjuvant therapy in patients with muscle-invasive bladder cancer: a single-centre study of 163 patients.
Miyata Y; Nomata K; Ohba K; Matsuo T; Hayashi N; Sakamoto I; Uetani M; Sakai H
Eur J Surg Oncol; 2015 Mar; 41(3):361-7. PubMed ID: 25312685
[TBL] [Abstract][Full Text] [Related]
16. Results of the phase II EORTC 22971 trial evaluating combined accelerated external radiation and chemotherapy with 5FU and cisplatin in patients with muscle invasive transitional cell carcinoma of the bladder.
Poortmans PM; Richaud P; Collette L; Ho Goey S; Pierart M; Van Der Hulst M; Bolla M;
Acta Oncol; 2008; 47(5):937-40. PubMed ID: 18568488
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic interventions targeting organ preservation in muscle-invasive bladder cancer: a review.
Koukourakis G; Kouloulias V; Zacharias G; Sotiropoulou-Lontou A; Koukourakis M
Clin Transl Oncol; 2011 May; 13(5):315-21. PubMed ID: 21596659
[TBL] [Abstract][Full Text] [Related]
18. Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor.
Bryant CM; Dang LH; Stechmiller BK; Gilbert SM; Morris CG; Zlotecki RA
Am J Clin Oncol; 2016 Feb; 39(1):69-75. PubMed ID: 24517956
[TBL] [Abstract][Full Text] [Related]
19. Selective bladder preservation by combination treatment of invasive bladder cancer.
Kaufman DS; Shipley WU; Griffin PP; Heney NM; Althausen AF; Efird JT
N Engl J Med; 1993 Nov; 329(19):1377-82. PubMed ID: 8413433
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis and treatment of bladder cancer.
Sharma S; Ksheersagar P; Sharma P
Am Fam Physician; 2009 Oct; 80(7):717-23. PubMed ID: 19817342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
